Antimutagenic Constituents of Casimiroa edulis with Potential Cancer Chemopreventive Activity

Journal of Agricultural and Food Chemistry

Volumn 46, Issue 9, 1998, Pages 3509-3516

  Ito, Aiko ^a   Shamon, Lisa A ^a,b   Yu, Boyang ^a   Mata Greenwood, Eugenia ^a   Lee, Sang Kook ^a   Van Breemen, Richard B ^a   Mehta, Rajendra G ^c   Farnsworth, Norman R ^a   Fong, Harry H S ^a   Pezzuto, John M ^a,c   Kinghorn, A Douglas ^a  

^a Chicago College of Pharmacy   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

(R,S) 5 methoxy 8 (6,7 dihydroxy 3,7 dimethyl 2 octenyl)oxy psoralen; (R,S) 8 (6,7 dihydroxy 3,7 dimethyl 2 octenyl)oxy psoralen; Alkaloids; Antimutagens; Casimiroa edulis; Flavonoids; Furocoumarins; Mouse mammary organ culture assay; Rutaceae

Indexed keywords

CASIMIROA EDULIS; OXY; RUTACEAE; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0000441881     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf9802373     Document Type: Article

References (75)

1. Achenbach, H. Progress in the chemistry of alkaloids with pharmacological or biological activity. In New Natural Products and Plant Drugs with Pharmacological, Biological or Therapeutical Activity; Wagner, H., Wolff, P., Eds.; Springer-Verlag: Berlin, 1977; pp 108-136.
2. Aebi, A. Über die Isolierung von Casimiroedin aus den Samen von Casimiroa edulis La Llave et Lejarza. Helv. Chim. Acta 1956, 39, 1495-1500.
3. Ahn, D.; Putt, D.; Kresty, L.; Stoner, G. D.; Fromm, D.; Hollenberg, P. F. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis 1996, 17, 821-828.
4. Burke, M. D.; Mayer, R. T. Inherent specificities of purified cytochromes P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation. Drug Metab. Dispos. 1975, 3, 245-253.
5. Burke, M. D.; Thompson, S.; Elcombe, C. R.; Halpert, J.; Haaparanta, T.; Mayer, R. T. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 1985, 34, 3337-3345.
6. Cai, Y.; Bennett, D.; Nair, R. V.; Ceska, O.; Ashwood-Smith, M. J.; DiGiovanni, J. Inhibition and inactivation of murine hepatic ethoxy- and pentoxyresorufm O-dealkylase by naturally occurring coumarins. Chem. Res. Toxicol. 1993, 6, 872-879.
7. De Flora, S.; Ramel, C. Mechanisms of inhibition of mutagenesis and Carcinogenesis. Classification and overview. Mutat. Res. 1988, 202, 285-306.
8. De Flora, S.; Camoirano, A.; D'Agostini, F.; Balansky, R. Modulation of the mutagenic response in prokaryotes. Mutat. Res. 1992, 267, 183-192.
9. Djerassi, C.; Herran, J.; Khastgir, H. N.; Riniker, B.; Romo, J. Alkaloid Studies. XV. Casimiroedine. J. Org. Chem. 1956, 21, 1510-1511.
10. Djerassi, C.; Bankiewicz, C.; Kappor, A. L.; Roniker, B. Alkaloid studies. XXI. Partial structure of casimiroedine. Tetrahedron 1958, 2, 168a-172.
11. Dreyer, D. L. Citrus bitter principles. IX. Extractives of Casimiroa edulis Llave et Lex. Structure of zapoterin. J. Org. Chem. 1968, 33, 3577-3582.
12. Dreyer, D. L.; Bertelli, D. J. The structure of zapotin. Tetrahedron 1967, 23, 4607-4612.
13. Ducharme, M. P.; Warbasse, L. H.; Edwards, D. J. Disposition of intravenous and oral cyclosporin after administration with grapefruit juice. Clin. Pharmacol. Ther. 1995, 57, 485-491.
14. Edwards, D. J.; Bellevue, F. H., III; Woster, P. M. Identification of 6′,7′-dihydroxybergamottin, a cytochrome P-450 inhibitor, in grapefruit juice. Drug Metab. Dispos. 1996, 24, 1287-1290.
15. 13C NMR chemical shifts and carbon-proton coupling constants of some furocoumarins and furochromones. Phytochemistry 1979, 18, 139-143.
16. Enríquez, R. G.; Romero, M. L.; Escobar, L. L; Joseph-Nathan, P.; Reynolds, W. F. High-performance liquid chromatographic study of Casimiroa edulis. II. Determination of furocoumarins. J. Chromatogr. 1984, 287, 209-214.
17. Garratt, P. J.; Scheinmann, F.; Sondheimer, F. Constituents of Casimiroa edulis Llave et Lex. VIII. The structures of zapotin and zapotinin. Tetrahedron 1967, 23, 2413-2416.
18. Gerhäuser, C.; Mar, W.; Lee, S. K.; Suh, N.; Luo, Y.; Kosmeder, J.; Moriarty, R. M.; Luyengi, L.; Kinghorn, A. D.; Fong, H. H. S.; Mehta, R. G.; Constantinou, A.; Moon, R. C.; Pezzuto, J. M, Rotenoids mediate potent chemopreventive activity through transcriptional regulation of ornithine decarboxylase. Nat. Med. 1995, 1, 260-266.
19. Grüter, A.; Friederich, U.; Würgler, F. E. Antimutagenic effects of mushrooms. Mutat. Res. 1990, 231, 243-249.
20. Guo, Z.; Smith, T. J.; Wang, E.; Sadrieh, N.; Ma, Q.; Thomas, P. E.; Yang, C. S. Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosoamine metabolism in rat. Carcinogenesis 1992, 13, 2205-2210.
21. Hafele, F.; Schimmer O. Mutagenicity of furoquinoline alkaloids in the Salmonella/microsome assay. Mutagenicity of dictamnine is modified by various enzyme inducers and inhibitors. Mutagenesis 1988, 3, 349-353.
22. Hart, K. N.; Johns, R. S.; Lamberton, A. J.; Price, R. J. Alkaloids of the Australian Rutaceae: Lunasia quercifolia. Aust J. Chem. 1968, 21, 1389-1391.
23. Ho, C.-T., Osawa, T., Huang, M.-T., Rosen, R. T., Eds. Food Phytochemicals for Cancer Prevention II Teas, Spices, and Herbs; ACS Symposium Series 547; American Chemical Society: Washington, DC, 1994.
24. Huang, M.-T., Osawa, T., Ho, C.-T., Rosen, R. T., Eds. Food Phytochemicals for Cancer Prevention I. Fruits and Vegetables; ACS Symposium Series 546; American Chemical Society: Washington, DC, 1994.
25. Iriarte, J.; Kincl, F. A.; Rosenkranz, G.; Sondheimer, F, The constituents of Casimiroa edulis Llave et Lex. Part II. The Bark. J. Chem. Soc. 1956, 4170-4173.
26. Kada, T.; Inoue, T.; Namiki, M. In Environmental Mutagenesis, Carcinogenesis and Plant Biology; Klekowski Jr., E. J., Ed.; Praeger Scientific: New York, 1981; pp 132-151.
27. Kada, Y.; Inoue, T.; Ohta, T.; Shirasu, Y. Antimutagens and their modes of action. In Antimutagenesis and Anticarcinogenesis Mechanisms; Shankel, D. M., Hartman, P. E., Kada, T., Hollaender, A., Eds.; Plenum Press: New York, 1986; pp 181-196.
28. Kanamori, H.; Sakamoto, I.; Mizuta, M. Further study on mutagenic furoquinoline alkaloids of Dictamni Radicis cortex: isolation of skimmianine and high-performance liquid Chromatographic analysis. Chem. Pharm. Bull. 1986, 34, 1826-1829.
29. Kavli, G.; Raa, J.; Johnson, B. E.; Volden, G.; Haugsbo, S. Furocoumarins of Heracleum laciniatum: isolation, phototoxicity, absorption and action spectra studies. Contact Dermatitis 1983, 9, 257-262.
30. Kelloff, G. J.; Boone, C. W.; Crowell, J. A.; Steele, V. E.; Lubet, R. A.; Sigman, C. S. Chemopreventive drug development: perspective and progress. Cancer Epidem. Biomarkers Prevent. 1994, 3, 83-98.
31. Kind, F. A.; Romo, J.; Rosenkranz, G.; Sondheimer, F. The constituents of Casimiroa edulis Llave et Lex. Part I. The seeds. J. Chem. Soc. 1956, 4163-4169.
32. Kuroda, Y.; Inoue, T. Antimutagenesis by factors affecting DNA repair in bacteria. Mutat. Res. 1988, 202, 387-391.
33. Lichti, U.; Gottesman, M. M. Genetic evidence that a phorbol ester tumor promoter stimulates ornithine decarboxylase activity by a pathway that is independent of cyclic AMP-dependent protein kinases in CHO cells. J. Cell. Physiol. 1982, 113, 433-439.
34. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. Protein mesurement with the folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
35. Magos, G. A.; Vidrio, H. Pharmacology of Casimiroa edulis. Part I. Blood pressure and heart rate effects in anesthetized rat. Planta Med. 1991, 57, 20-24.
36. Magos, G. A.; Vidrio, H.; Enriquez, R, Pharmacology of Casimiroa edulis. III. Relaxant and contractile effects in rat aortic rings. J. Ethnopharmacol. 1995, 47, 1-8.
37. Maron, D. M.; Ames, B. N. Revised methods for the Salmonella mutagenicity test. Mutat Res. 1983, 113, 173-215.
38. Mechoulam, R.; Sondheimer, F.; Melera, A.; Kind, F. A. The structure of zapotidine. J. Am. Chem. Soc. 1961, 83, 2022-2023.
39. Mehta, R. G.; Steele, V.; Kelloff, G. J.; Moon, R. C. Influence of thiols and inhibitors of prostaglandin biosynthesis on the carcinogen-induced development of mammary lesions in vitro. Anticancer Res. 1991, 11, 587-592.
40. Meisels, A.; Sondheimer, F. The constituents of Casimiroa edulis Llave et Lex. III. The structure of casimiroin. J. Am. Chem. Soc. 1957, 79, 6328-6333.
41. Melski, J. W.; Tanenbaum, L.; Parrish, J. A.; Fitzpatrick, T. B.; Bleich, H. L. Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J. Invest. Dermatol. 1977, 68, 328-335.
42. Mizuta, M.; Kanamori, H. Mutagenic activities of dictamnine and γ-fagarine from Dictamni Radicis cortex (Rutaceae). Mutat. Res. 1985, 144, 221-225.
43. Murphy, J. W.; Toube, T.; Cross, D. A. Spectra and stereo-chemistry. XXIX. The structure of zapoterin. Tetrahedron 1968, 49, 5153-5156.
44. Narasimhan, N. S.; Mali, R. S. Synthetic application of lithiation reactions. VI. New synthesis of linear furoquinoline alkaloids. Tetrahedron 1974, 30, 4153-4157.
45. Navarro, R. A.; Bastidas, R. B. E.; Garcia, E. J.; Garcia, L. P.; Garzon, P. Anticonvulsant activity of Casimiroa edulis in comparison to phenytoin and phenobarbital. J. Ethnopharmacol. 1995, 45, 199-206.
46. Nayar, M. N. S., Sutar, C. V.; Bhan, M. K. Alkaloids of the stem bark of Hesperethusa crenulata. Phytochemistry 1971, 10, 2843-2844.
47. O'Dowd, J. J.; Burnett, A. K.; Weston, A.; Bulleid, N. J.; Craft, J. A. Alterations in the metabolism of 7,12-dimethylbenz-[a]anthracene and various xenobiotics by rat hepatic microsomes following Sudan III treatment in vivo. Carcinogenesis 1988, 9, 1485-1491.
48. Panzica, R. P.; Townsend, L. B. The total synthesis of the alkaloid casimiroedine, an imidazole nucleoside. J. Am. Chem. Soc. 1973, 95, 8737-8740.
49. Paulini, H.; Eilert, U.; Schimmer, O. Mutagenic compounds in an extract from Rutae Herba (Ruta graveolens L.). I. Mutagenicity is partially caused by furoquinoline alkaloids. Mutagenesis 1987, 2, 271-273.
50. Paulini, H.; Waiber, R.; Schimmer, O. Mutagenicity and structure-mutagenicity relationships of furoquinolines, naturally occurring alkaloids of the Rutaceae. Mutat. Res. 1989, 227, 179-186.
51. Petit-Paly, G.; Rideau, M.; Chenieux, C. J, Etude de quelques Rutacees a alcaloides. II. Ruta graveolens: Revue botanique, chimique et pharmacologique. (Etude particuliere des alcaloides quaternaires quinoleiques). Plant. Med. Phytother. 1982, 16, 55-72.
52. Pezzuto, J. M. Natural product cancer chemopreventive agents. In Recent Advances in Phytochemistry, Vol. 29, Phytochemistry of Medicinal Plants; Arnason, J. T., Mata, R., Romeo, J. T., Eds.; Plenum Press: New York, 1995; pp 19-45.
53. Power, F. B.; Callan, T. The consituents of the seeds of Casimiroa edulis. J. Chem. Soc. 1911, 1993-2012.
54. Raman, S.; Reddy, J.; Lipscomb, W. N.; Kapoor, A. L.; Djerassi, C. Structure of the alkaloid casimiroedine. Tetrahedron Lett. 1962, 9, 357-360.
55. α-Dimethylhistamine, a hypotensive principle in Casimiroa edulis Llave et Lex. J. Org. Chem. 1958, 23, 1564-1565.
56. Rizvi, S. H.; Kapil, R. S.; Shoeb, A. Alkaloids and coumarins of Casimiroa edulis. J. Nat. Prod. 1985, 48, 146.
57. Romero, M. L.; Escobar, L. L; Lozoya, X.; Enríquez, R. G. High-performance liquid chomatographic study of Casimiroa edulis. I. Determination of imidazole derivatives and rutin in aqueous and organic extracts. J. Chromatogr. 1983, 281, 245-251.
58. Saiki, Y.; Uchida, M.; Okegawa, O.; Fukushima, S. On the mass spectra of several furanocoumarins having various isoprenoidal residues. Chem. Pharm. Bull. 1974, 22, 1227-1232.
59. Schimmer, O.; Leimeister, U, Gamma-Fagarin, ein Furochinolinalkaloid aus Ruta graveolens L., induziert SCE in menschlichen lymphocyten in vitro. Arch. Pharm. 1988, 321, 637.
60. Schimmer, O.; Kiefer, J.; Paulini, H. Inhibitory effects of furocoumarins in Salmonella typhimurium TA98 on the mutagenicity of dictamnine and rutacridone, promutagens from Ruta graveolens L. Mutagenesis 1991, 6, 501-506.
61. Shamon, L. A.; Chen, C.; Mehta, R. G.; Steele, V.; Moon, R. C.; Pezzuto, J. M. A correlative approach for the identification of antimutagens that demonstrate chemopreventive activity. Anticancer Res. 1994, 14, 1775-1778.
62. Shimada, T.; Guengerich, F. P. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in the human liver. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 462-465.
63. Shin, K. H.; Woo, W. S. The mode of the activity of naturally occurring furanocoumarins on hepatic cytochrome P-450 enzyme system. Kor. J. Pharmacog. 1990, 211, 74-82.
64. Skopek, T. R.; Liber, H. L.; Kaden, D. A.; Thilly, W. G. Relative sensitivities of forward and reverse mutation assays in Salmonella typhimurium. Proc. Natl. Acad. Sci U.S.A. 1978, 75, 4465-4469.
65. Sondheimer, F.; Meisels, A. The constituents of Casimiroa edulis Llave et Lex. IV. Identification of edulin with 7-methyl-1-methyl-2-phenyl-4-quinolone. J. Org. Chem. 1958, 23, 762-763.
66. Sondheimer, F.; Meisels, A. Constituents of Casimiroa edulis Llave et Lex. VI. 2′,5′,6-trimethoxy flavone, 2′,5,6,7-tetra-methoxyflavone (zapotin) and 5-hydroxy-2′,6,7-trimethoxyflavone (zapotinin). Tetrahedron 1960, 9, 139-144.
67. Sondheimer, F.; Meisels, A.; Kincl, F. A. Constituents of Casimiroa edulis Llave et Lex. V. Identity of casimirolid and obacunone. J. Org. Chem. 1959, 24, 870.
68. Sporn, M. B.; Dunlop, N. M.; Newton, D. L.; Smith, J. M. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed. Proc. 1976, 35, 1332-1338.
69. Suh, N.; Luyengi, L.; Fong, H. H. S.; Kinghorn, A. D.; Pezzuto, J. M. Discovery of natural product chemopreventive agents using HL-60 cell differentiation as a model. Anticancer Res. 1995, 15, 233-238.
70. Toube, T. P.; Murphy, J. W.; Cross, A. D. The structures of edulitine and edulinine. XXIV. Spectra and stereochemistry. Tetrahedron 1967, 23, 2061-2065.
71. Vidrio, H.; Magos, G. A. Pharmacology of Casimiroa edulis. II. Cardiovascular effects in the anesthesized dog. Planta Med. 1991, 57, 217-220.
72. Wall, M. E. Antimutagenic agents from natural products. J. Nat. Prod. 1992, 55, 1561-1568.
73. Wall, M. E.; Wani, M. C.; Manikumar, G.; Hughes, T. J.; Taylor, H.; McGivney, R.; Warner, J. Plant antimutagenic agents, 3. Coumarins. J. Nat. Prod. 1988, 51, 1148-1152.
74. Weinstein, B.; Hylton, T. A. Heterocyclic compounds. V. The synthesis of casimiroin. Tetrahedron 1964, 20, 1725-1728.
75. Wollenweber, E.; Iinuma, M.; Tanaka, T.; Mizuno, M. 5-Hydroxy-6,2′-dimethoxyflavone from Primula denticulata. Phytochemistry 1990, 29, 633-637.